Cargando…
Bioassay for total serum bioactivity of Atractylodes lancea
The study aimed to establish a bioassay for total bioactivity of Atractylodes lancea (AL) in human serum samples. Inhibition of bacterial growth (Staphylococcus aureus ATCC 25923) was assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. The calibration curve (0, 0.39, 0...
Autores principales: | Na-Bangchang, Kesara, Cheoymang, Anurak, Muhamad, Nadda, Kulma, Inthuon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026330/ https://www.ncbi.nlm.nih.gov/pubmed/36950462 http://dx.doi.org/10.4103/japtr.japtr_431_22 |
Ejemplares similares
-
Phase I clinical trial to evaluate the safety and pharmacokinetics of capsule formulation of the standardized extract of Atractylodes lancea
por: Na-Bangchang, Kesara, et al.
Publicado: (2021) -
A randomized placebo-controlled phase I clinical trial to evaluate the immunomodulatory activities of Atractylodes lancea (Thunb) DC. in healthy Thai subjects
por: Kulma, Inthuon, et al.
Publicado: (2021) -
Atractylodes lancea for cholangiocarcinoma: Modulatory effects on CYP1A2 and CYP3A1 and pharmacokinetics in rats and biodistribution in mice
por: Muhamad, Nadda, et al.
Publicado: (2022) -
Bioactive constituents isolated from Atractylodes lancea (Thunb.) DC. rhizome exhibit synergistic effect against cholangiocarcinoma cell
por: Martviset, Pongsakorn, et al.
Publicado: (2018) -
Suppression of Cholangiocarcinoma Cell Growth and Proliferation by Atractylodes lancea (Thunb) DC. through ERK-Signaling Cascade
por: Martviset, Pongsakorn, et al.
Publicado: (2021)